Dupilumab helps severe asthma patients cut glucocorticoid use

Research has shown dupilumab reduces glucocorticoid use by more than 70% and the number of severe asthma exacerbations by almost 60%.

Source: Clinical Pharmacist - July 11, 2018 Category: Drugs & Pharmacology Source Type: research